Report cover image

Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033

Publisher The Business Research Company
Published Jan 27, 2025
Length 278 Pages
SKU # BRC19511461

Description

Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033

Including: 1) By Type: Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM); Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN)2) By Drug: Tafamidis; Patisiran; Inotersen3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Pfizer Inc.; Alnylam Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; BridgeBio Pharma, Inc.; Intellia Therapeutics Inc.


Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global transthyretin amyloidosis treatment market as it emerges from the COVID-19 shut down.

Reasons to Purchase:
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description:

Where is the largest and fastest-growing market for transthyretin amyloidosis treatment? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The transthyretin amyloidosis treatment market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider transthyretin amyloidosis treatment market; and compares it with other markets.

The report covers the following chapters
  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by drug and by distribution channel.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario - The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the transthyretin amyloidosis treatment market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
    • Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
    • Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by drug and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
    • Regional Market Size and Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
    • Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
    • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
    • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
    • Competitive Dashboard- Briefs on competitive dashboard of major players.
    • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
    • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
    • Conclusions And Recommendations- This section includes recommendations for transthyretin amyloidosis treatment providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
    • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
    Markets Covered:

    1) By Type: Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM); Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN)

    2) By Drug: Tafamidis; Patisiran; Inotersen; Other Drugs

    3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

    Companies Mentioned: Pfizer Inc.; Alnylam Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; BridgeBio Pharma, Inc.; Intellia Therapeutics Inc.

    Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia.

    Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

    Time-series: Five years historic and ten years forecast.

    Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; transthyretin amyloidosis treatment indicators comparison.

    Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

    Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

    Table of Contents

    278 Pages
    1 Executive Summary
    1.1 Transthyretin Amyloidosis Treatment – Market Attractiveness And Macro Economic Landscape
    2 Table Of Contents
    3 List Of Tables
    4 List Of Figures
    5 Report Structure
    6 Market Characteristics
    6.1 General Market Definition
    6.2 Summary
    6.3 Transthyretin Amyloidosis Treatment Market Definition And Segmentations
    6.4 Market Segmentation By Type
    6.4.1 Transthyretin Amyloidosis With Polyneuropathy
    6.4.2 Transthyretin Amyloidosis With Cardiomyopathy
    6.5 Market Segmentation By Drug
    6.5.1 Tafamidis
    6.5.2 Patisiran
    6.5.3 Inotersen
    6.5.4 Other Drugs
    6.6 Market Segmentation By Distribution Channel
    6.6.1 Hospital Pharmacies
    6.6.2 Retail Pharmacies
    6.6.3 Online Pharmacies
    7 Major Market Trends
    7.1 Advancing Treatment Options For Amyloidosis With Novel Therapeutic Antibody
    8 Transthyretin Amyloidosis Treatment Market - Macro Economic Scenario
    8.1 COVID-19 Impact On The Transthyretin Amyloidosis Treatment Market
    8.2 Impact Of The War In Ukraine On The Transthyretin Amyloidosis Treatment Market
    8.3 Impact Of High Inflation On The Transthyretin Amyloidosis Treatment Market
    9 Global Market Size and Growth
    9.1 Market Size
    9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)
    9.2.1 Market Drivers 2018 – 2023
    9.2.2 Market Restraints 2018 – 2023
    9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)
    9.3.1 Market Drivers 2023 – 2028
    9.3.2 Market Restraints 2023 – 2028
    10 Global Transthyretin Amyloidosis Treatment Market Segmentation
    10.1 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    10.2 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    10.3 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    11 Transthyretin Amyloidosis Treatment Market, Regional and Country Analysis
    11.1 Global Transthyretin Amyloidosis Treatment Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    11.2 Global Transthyretin Amyloidosis Treatment Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12 Asia-Pacific Market
    12.1 Summary
    12.2 Market Overview
    12.2.1 Region Information
    12.2.2 Market Information
    12.2.3 Background Information
    12.2.4 Government Initiatives
    12.2.5 Regulations
    12.2.6 Regulatory Bodies
    12.2.7 Major Associations
    12.2.8 Taxes Levied
    12.2.9 Corporate Tax Structure
    12.2.10 Investments
    12.2.11 Major Companies
    12.3 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.4 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.5 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.6 China Market
    12.7 Summary
    12.8 Market Overview
    12.8.1 Country Information
    12.8.2 Market Information
    12.8.3 Background Information
    12.8.4 Government Initiatives
    12.8.5 Regulations
    12.8.6 Regulatory Bodies
    12.8.7 Major Associations
    12.8.8 Taxes Levied
    12.8.9 Corporate Tax Structure
    12.8.10 Major Companies
    12.9 China Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.10 China Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.11 China Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.12 India Market
    12.13 India Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.14 India Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.15 India Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.16 Japan Market
    12.17 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.18 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.19 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.20 Australia Market
    12.21 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.22 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.23 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.24 Indonesia Market
    12.25 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.26 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.27 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.28 South Korea Market
    12.29 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.30 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    12.31 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13 Western Europe Market
    13.1 Summary
    13.2 Market Overview
    13.2.1 Region Information
    13.2.2 Market Information
    13.2.3 Background Information
    13.2.4 Government Initiatives
    13.2.5 Regulations
    13.2.6 Regulatory Bodies
    13.2.7 Major Associations
    13.2.8 Taxes Levied
    13.2.9 Corporate tax structure
    13.2.10 Investments
    13.2.11 Major Companies
    13.3 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.4 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.5 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.6 Western Europe Transthyretin Amyloidosis Treatment Market: Country Analysis
    13.7 UK Market
    13.8 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.9 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.10 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.11 Germany Market
    13.12 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.13 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.14 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.15 France Market
    13.16 France Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.17 France Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.18 France Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.19 Italy Market
    13.20 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.21 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.22 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.23 Spain Market
    13.24 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.25 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    13.26 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14 Eastern Europe Market
    14.1 Summary
    14.2 Market Overview
    14.2.1 Region Information
    14.2.2 Market Information
    14.2.3 Background Information
    14.2.4 Government Initiatives
    14.2.5 Regulations
    14.2.6 Regulatory Bodies
    14.2.7 Major Associations
    14.2.8 Taxes Levied
    14.2.9 Corporate Tax Structure
    14.2.10 Investments
    14.2.11 Major companies
    14.3 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.4 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.5 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.6 Eastern Europe Transthyretin Amyloidosis Treatment Market: Country Analysis
    14.7 Russia Market
    14.8 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.9 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    14.10 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15 North America Market
    15.1 Summary
    15.2 Market Overview
    15.2.1 Region Information
    15.2.2 Market Information
    15.2.3 Background Information
    15.2.4 Government Initiatives
    15.2.5 Regulations
    15.2.6 Regulatory Bodies
    15.2.7 Major Associations
    15.2.8 Taxes Levied
    15.2.9 Corporate Tax Structure
    15.2.10 Investments
    15.2.11 Major Companies
    15.3 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.4 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.5 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.6 North America Transthyretin Amyloidosis Treatment Market: Country Analysis
    15.7 USA Market
    15.8 Summary
    15.9 Market Overview
    15.9.1 Country Information
    15.9.2 Market Information
    15.9.3 Background Information
    15.9.4 Government Initiatives
    15.9.5 Regulations
    15.9.6 Regulatory Bodies
    15.9.7 Major Associations
    15.9.8 Taxes Levied
    15.9.9 Corporate Tax Structure
    15.9.10 Investments
    15.9.11 Major Companies
    15.10 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.11 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.12 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.13 Canada Market
    15.14 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.15 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    15.16 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16 South America Market
    16.1 Summary
    16.2 Market Overview
    16.2.1 Region Information
    16.2.2 Market Information
    16.2.3 Background Information
    16.2.4 Government Initiatives
    16.2.5 Regulations
    16.2.6 Regulatory Bodies
    16.2.7 Major Associations
    16.2.8 Taxes Levied
    16.2.9 Corporate Tax Structure
    16.2.10 Investments
    16.2.11 Major Companies
    16.3 South America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.4 South America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.5 South America Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.6 South America Transthyretin Amyloidosis Treatment Market: Country Analysis
    16.7 Brazil Market
    16.8 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.9 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    16.10 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    17 Middle East Market
    17.1 Summary
    17.2 Market Overview
    17.2.1 Region Information
    17.2.2 Market Information
    17.2.3 Background Information
    17.2.4 Government Initiatives
    17.2.5 Regulations
    17.2.6 Regulatory Bodies
    17.2.7 Major Associations
    17.2.8 Taxes Levied
    17.2.9 Corporate Tax Structure
    17.2.10 Major Companies
    17.3 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    17.4 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    17.5 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    18 Africa Market
    18.1 Summary
    18.2 Market Overview
    18.2.1 Region Information
    18.2.2 Market Information
    18.2.3 Background Information
    18.2.4 Government Initiatives
    18.2.5 Regulations
    18.2.6 Regulatory Bodies
    18.2.7 Major Associations
    18.2.8 Taxes Levied
    18.2.9 Major Companies
    18.3 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    18.4 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    18.5 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
    19 Competitive Landscape And Company Profiles
    19.1 Company Profiles
    19.2 Pfizer Inc
    19.2.1 Company Overview
    19.2.2 Products And Services
    19.2.3 Business Strategy
    19.2.4 Financial Overview
    19.3 Alnylam Pharmaceuticals, Inc
    19.3.1 Company Overview
    19.3.2 Products And Services
    19.3.3 Business Strategy
    19.3.4 Financial Overview
    19.4 Ionis Pharmaceuticals, Inc
    19.4.1 Company Overview
    19.4.2 Products And Services
    19.4.3 Business Strategy
    19.4.4 Financial Overview
    19.5 BridgeBio Pharma, Inc
    19.5.1 Company Overview
    19.5.2 Products And Services
    19.5.3 Business Strategy
    19.6 Intellia Therapeutics Inc
    19.6.1 Company Overview
    19.6.2 Products And Services
    19.6.3 Business Strategy
    20 Other Major And Innovative Companies
    20.1 AstraZeneca
    20.1.1 Company Overview
    20.1.2 Products And Services
    20.2 Novo Nordisk A/S
    20.2.1 Company Overview
    20.2.2 Products And Services
    20.3 PTC Therapeutics Inc.
    20.3.1 Company Overview
    20.3.2 Products And Services
    20.4 Bristol-Myers Squibb Company
    20.4.1 Company Overview
    20.4.2 Products And Services
    20.5 Abbvie Inc.
    20.5.1 Company Overview
    20.5.2 Products And Services
    20.6 SOM Biotech
    20.6.1 Company Overview
    20.6.2 Products And Services
    20.7 Corino Therapeutics Inc.
    20.7.1 Company Overview
    20.7.2 1.7.2 Products And Services
    20.8 Acrotech Biopharma Inc.
    20.8.1 Company Overview
    20.8.2 Products And Services
    20.9 Neurimmune AG
    20.9.1 Company Overview
    20.9.2 Products And Services
    20.10 Sorrento Therapeutics, Inc.
    20.10.1 Company Overview
    20.10.2 Products And Services
    20.11 Oncopeptides AB
    20.11.1 Company Overview
    20.11.2 Products And Services
    20.12 Takeda Pharmaceutical Company Limited
    20.12.1 Company Overview
    20.12.2 Products And Services
    20.13 Astellas Pharma, Inc.
    20.13.1 Company Overview
    20.13.2 Products And Services
    20.14 GSK plc
    20.14.1 Company Overview
    20.14.2 Products And Services
    20.15 Bausch Health Company
    20.15.1 Company Overview
    20.15.2 Products And Services
    21 Competitive Benchmarking
    22 Competitive Dashboard
    23 Key Mergers And Acquisitions
    23.1 Astellas Pharma Acquired Polyphor International
    23.2 AstraZeneca Acquired Caelum Biosciences
    23.3 Novo Nordisk Acquired Prothena Corporation
    24 Opportunities And Strategies
    24.1 Global Transthyretin Amyloidosis Treatment Market In 2028 – Countries Offering Most New Opportunities
    24.2 Global Transthyretin Amyloidosis Treatment Market In 2028 – Segments Offering Most New Opportunities
    24.3 Global Transthyretin Amyloidosis Treatment Market In 2028 – Growth Strategies
    24.3.1 Market Trend Based Strategies
    24.3.2 Competitor Strategies
    25 Transthyretin Amyloidosis Treatment Market, Conclusions And Recommendations
    25.1 Conclusions
    25.2 Recommendations
    25.2.1 Product
    25.2.2 Place
    25.2.3 Price
    25.2.4 Promotion
    25.2.5 People
    26 Appendix
    26.1 Geographies Covered
    26.2 Market Data Sources
    26.3 Research Methodology
    26.4 Currencies
    26.5 The Business Research Company
    26.6 Copyright and Disclaimer

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Request A Sample
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us